MOESM3 of Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin

Additional file 3. Saxagliptin and 5-hydroxy saxagliptin pharmacokinetic parameters for multiple ascending dose study in patients with T2DM.